Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.

Author: BlackwoodR Alexander, KleinKristin C

Paper Details 
Original Abstract of the Article :
Invasive aspergillosis seems to be on the rise, especially in immunocompromised children. Historically, only systemic amphotericin B has been effective against Aspergillus. Development of newer antifungal agents, such as voriconazole and caspofungin, has improved the treatment options available for ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1542/peds.2005-2213

データ提供:米国国立医学図書館(NLM)

Combating Cutaneous Aspergillosis: A Multi-pronged Approach

The rise of invasive aspergillosis, particularly in immunocompromised children, necessitates a comprehensive approach to treatment. This research reports the successful use of topical voriconazole solution combined with systemic antifungal agents for cutaneous aspergillosis in a pediatric patient after bone marrow transplant. The authors highlight the potential of topical voriconazole as an adjunct therapy for managing this challenging infection.

A New Weapon in the Fight Against Aspergillosis

This case report suggests that topical voriconazole, in combination with systemic antifungal agents, can be an effective treatment option for cutaneous aspergillosis in pediatric patients after bone marrow transplant. The authors demonstrate the potential of a multi-pronged approach to combating this challenging infection, offering hope for improved outcomes for immunocompromised children.

Navigating the Desert of Infection

This research highlights the importance of exploring new and innovative treatment approaches for challenging infections like aspergillosis. The authors' successful use of topical voriconazole in combination with systemic antifungal agents underscores the potential of multi-pronged therapies for managing this condition. It's like navigating a vast desert - you need to be prepared for unexpected challenges and have a range of tools at your disposal to ensure success.

Dr. Camel's Conclusion

This research explores the potential of topical voriconazole solution, in combination with systemic antifungal agents, for managing cutaneous aspergillosis in a pediatric patient after bone marrow transplant. The case report demonstrates the potential of a multi-pronged approach to combating this challenging infection, offering hope for improved outcomes for immunocompromised children. It's like navigating a vast desert - sometimes you need to find new pathways and combine different strategies to overcome unexpected challenges.

Date :
  1. Date Completed 2006-09-11
  2. Date Revised 2014-11-20
Further Info :

Pubmed ID

16816005

DOI: Digital Object Identifier

10.1542/peds.2005-2213

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.